B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signalling to RAS

REACTOME PATHWAY
Reactome: R-HSA-1670448 genes24 compounds

The Signalling to RAS pathway (Reactome ID: R-HSA-167044) involves 8 genes and is affected by 24 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

GRB2MAPK11MAPK12MAPK13MAPK14MAPKAPK2NTRK1SRC

Compounds Affecting Signalling to RAS

#CompoundTargets HitStudies
1Sorafenib300
2Afatinib297
3Anisomycin247
4isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
5withaferin300
6Dasatinib299
7Quercetin300
8tyrphostin ag 14784
9Crizotinib298
10sp600125117
11egcg300
12fisetin78
13myricetin-3-O-galactopyranoside [Supplementary Concept]300
14Celecoxib295
15Resveratrol298
16Adenosine Monophosphate Adenine nucleotide containing300
17alsterpaullone12
18kenpaullone8
19monorden8
20Niclosamide299
21Axitinib298
22pictilisib25
23Adenosine Triphosphate300
24Dactinomycin297

About the Signalling to RAS Pathway

The Signalling to RAS pathway is catalogued in Reactome (ID: R-HSA-167044) and involves 8 genes. In the BiohacksAI corpus, 24 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include GRB2, MAPK11, MAPK12, MAPK13, MAPK14.